Therapeutics and Clinical Risk Management
译名:治疗与临床风险管理
1-3
2026
影响因子区间
—
平台估算
70%
2025
中国作者发文占比
40000000 IRR;600 USD
收费
期刊简介:Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature. As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication. The journal does not accept study protocols, animal-based or cell line-based studies.
【译文】Therapeutics and Clinical Risk Management是一本国际同行评审的临床治疗和风险管理杂志,专注于所有治疗领域的临床研究、结果、安全性和药物、治疗和手术干预的有效、安全、持续使用的报告。该杂志欢迎提交原创研究、临床和流行病学研究、综述、指南、专家意见和评论。该杂志将考虑病例报告,但仅当它们对文献有有价值且原创的贡献时。截至2019年3月18日,Therapeutics and Clinical Risk Management将不再考虑发表荟萃分析。
| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |